Award

Delivery Order #SPE2DR26FM4WE

Delivery Order for Neupogen Vials under AmerisourceBergen IDV Contract

Buyer

Defense Logistics Agency

Award Amount

$1,280.20

Ceiling

$1,280.20

Awarded

February 20, 2026

Period of Performance

Feb 20, 2026 – Feb 23, 2026

Identifier

SPE2DR26FM4WE

NAICS

424210

This award is a delivery order contract under a pre-existing indefinite delivery vehicle (IDV) contract assigned to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor. The delivery order procures Neupogen 300 MCG/ML vials, a critical pharmaceutical product used in patient care to stimulate white blood cell production. The award ensures the continued supply of this essential medication, supporting public health and medical treatment efforts. The scope covers a short-term, specific procurement with defined quantities delivered to a location in Conshohocken, PA, demonstrating timely fulfillment under the IDV framework. This contract was awarded as part of a competitive, established vehicle designed to streamline pharmaceutical procurement. Key acquisition program details highlight its integration within broader pharmaceutical supply initiatives by the agency. The delivery order reflects AmerisourceBergen’s ongoing role in maintaining a reliable healthcare supply chain, building on their prior performance under the parent IDV contract awarded for pharmaceutical supplies. The contract spans a brief period in early 2026, ensuring prompt delivery to meet mission-critical needs.

Description

4570903772!NEUPOGEN 300 MCG/ML VIALML

View original record